Thoracic SMARCA4-Deficient Undifferentiated Tumor With ALK Fusion Treated With Alectinib Achieved Remarkable Tumor Regression: Case Report

Recently, SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) has emerged as a distinct subset of lung cancer. Previous studies have suggested that SMARCA4-UT is often associated with smoking-related mutations, such as KRAS and STK11, rather than EGFR or ALK alterations. Nevertheless, no specific...

詳細記述

書誌詳細

出版年:	JTO Clinical and Research Reports
主要な著者:	Jin Sheng, MD, Weidong Han, MD, PhD, Hongming Pan, MD, PhD
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2023-04-01
主題:	Non–small cell lung cancer Thoracic SMARCA4-deficient undifferentiated tumor ALK-rearranged Targeted therapy Case report
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2666364323000152